Holen Sie sich die Stockscreener-App
98.38
3.46%
3.29
Handel nachbörslich:
98.37
-0.010
-0.01%
Schlusskurs vom Vortag:
$95.09
Offen:
$94.61
24-Stunden-Volumen:
1.13M
Relative Volume:
0.77
Marktkapitalisierung:
$19.49B
Einnahmen:
$7.83B
Nettoeinkommen (Verlust:
$825.20M
KGV:
23.96
EPS:
4.1067
Netto-Cashflow:
$1.05B
1W Leistung:
-0.69%
1M Leistung:
-4.56%
6M Leistung:
-3.52%
1J Leistung:
-6.15%
1-Tages-Spanne:
$94.61
$98.74
1-Wochen-Bereich:
$94.01
$98.88
52-Wochen-Spanne:
$89.24
$114.72
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
98.38 | 18.84B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Will Zimmer Biomet Holdings Inc. see short term momentumMarket Performance Report & AI Forecast for Swing Trade Picks - newser.com
Price momentum metrics for Zimmer Biomet Holdings Inc. explainedJuly 2025 Price Swings & Verified Entry Point Signals - newser.com
What makes Zimmer Biomet Holdings Inc. stock attractive to growth fundsEarnings Growth Summary & Weekly High Conviction Ideas - newser.com
BTIG Adjusts Price Target on Zimmer Biomet Holdings to $122 From $118, Maintains Buy Rating - MarketScreener
Candlestick signals on Zimmer Biomet Holdings Inc. stock todayTrade Analysis Summary & Smart Money Movement Tracker - newser.com
Market reaction to Zimmer Biomet Holdings Inc.’s recent newsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Why Zimmer Biomet Holdings Inc. stock is recommended by analystsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Zimmer Biomet Earnings Preview: What to Expect - inkl
BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $12 - GuruFocus
Johnson Investment Counsel Inc. Sells 22,675 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (ZBH) Investor Outlook: Exploring A Potential 16.72% Upside - DirectorsTalk Interviews
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain institutional flowsChart Signals & Reliable Price Action Trade Plans - newser.com
Matrix Asset Advisors Inc. NY Lowers Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Q3 Earnings To Highlight Innovation And GrowthWhy I Think It's A Buy - Seeking Alpha
Analyzing drawdowns of Zimmer Biomet Holdings Inc. with statistical tools2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Costello Asset Management INC Sells 6,560 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Stock Position Raised by Callan Family Office LLC - MarketBeat
Zimmer Biomet Earnings Preview: What To Expect - Barchart.com
RBC Trims Price Target on Zimmer Biomet Holdings to $111 From $115, Keeps Outperform Rating - MarketScreener
Custom watchlist performance reports with Zimmer Biomet Holdings Inc.Market Activity Summary & Community Consensus Stock Picks - newser.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Truist Financial Corp - MarketBeat
Zimmer Biomet launches foot, ankle trauma systems - MassDevice
Tag Archives: foot and ankle trauma - InkFreeNews.com
Zimmer Biomet Launches Foot, Ankle Solutions For Complex Trauma Cases - InkFreeNews.com
Is Zimmer Biomet Holdings Inc. stock attractive after correctionAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Is Zimmer Biomet Holdings Inc ZIM a good long term investmentStock Price Divergence & Small Investment Portfolio Tips - earlytimes.in
Identifying reversal signals in Zimmer Biomet Holdings Inc.Weekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Janney Montgomery Scott LLC Acquires 9,482 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet's (ZBH) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Zimmer Biomet Completes Acquisition Of Orthopedic Robotics Company - InkFreeNews.com
Zimmer Biomet closes acquisition of Monogram Technologies - MSN
Zimmer Biomet launches new solutions for complex foot and ankle trauma - Investing.com Canada
Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions - Nasdaq
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases - PR Newswire
Robeco Institutional Asset Management B.V. Sells 10,504 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Secured Retirement Advisors LLC Invests $413,000 in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies - MarketScreener
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio - MassDevice
Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Tech - GuruFocus
Zimmer Biomet Acquires Monogram Orthopaedics on October 7, 2025 - TipRanks
Zimmer Biomet Acquires Monogram Technologies to Enhance Robotics - TipRanks
Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc.. - MarketScreener
Evercore ISI Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00 - MarketBeat
What analysts say about Zimmer Biomet Holdings Inc ZIM stockPrice-to-Earnings Ratio Insights & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Oct. 7Zimmer Biomet acquires AI-robotics orthopedic company Monogram Technologies - Fort Wayne Business Weekly
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M - GuruFocus
Evercore ISI Adjusts Zimmer Biomet Price Target to $104 From $106, Maintains In Line Rating - MarketScreener
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies - GuruFocus
Does Japan’s Approval of Iodine Hip Implants Alter the Bull Case for Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet Completes Acquisition of Monogram Technologies - WV News
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):